Robuta

https://www.mayo.edu/research/clinical-trials/cls-20519541
Learn more about services at Mayo Clinic.
enfortumab vedotinperioperativeevpluspembrolizumab
https://pubmed.ncbi.nlm.nih.gov/40128286/
Our findings indicate that chemotherapy can drive immunosuppressive TME modifications specific to CLDN18.2-positive GC.
gastric cancerneoadjuvant chemotherapypositivespecificchanges
https://pubmed.ncbi.nlm.nih.gov/32046998/
complete responseneoadjuvant chemotherapypathologicimpactbreast
https://pubmed.ncbi.nlm.nih.gov/36896856/
In recent years, the treatment of breast cancer has advanced dramatically and neoadjuvant chemotherapy (NAC) has become a common treatment method, especially...
neoadjuvant chemotherapydevelopmentmultipleaipipelines